石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01093 石药集团

休市中 04-26 16:08:20

6.600

+0.080

+1.23%

最高6.640	最低6.450	成交量4,718万
今开6.510	昨收6.520	日振幅2.91%
总市值786.90亿	流通市值786.90亿	总股本119.23亿
成交额3.10亿	换手率0.40%	流通股本119.23亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":6.6,"timestamp":1714118900029,"preClose":6.52,"halted":0,"volume":47181086,"delay":0,"floatShares":11922719732,"shares":11922719732,"eps":0.5332188,"marketStatus":"休市中","marketStatusCode":7,"change":0.08,"latestTime":"04-26 16:08:20","open":6.51,"high":6.64,"low":6.45,"amount":309673867,"amplitude":0.029141,"askPrice":6.61,"askSize":664000,"bidPrice":6.6,"bidSize":1492000,"shortable":3,"etf":0,"ttmEps":0.5331983106441941,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714354200000},"adr":0,"listingDate":772128000000,"adjPreClose":6.52,"dividendRate":0.041506,"openAndCloseTimeList":[[1714095000000,1714104000000],[1714107600000,1714118400000]],"volumeRatio":1.3982953090738168,"optionData":{"bulkOrders":[{"symbol":"CSP.HK","call":false,"expireDate":1716998400000,"strike":"6.25","timestamp":1714103346704,"price":0.14000000059604645,"volume":300,"amount":84000,"type":"*"},{"symbol":"CSP.HK","call":false,"expireDate":1722268800000,"strike":"5.75","timestamp":1714102625624,"price":0.18000000715255737,"volume":275,"amount":99000,"type":"*"}]},"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK"},"requestUrl":"/m/hq/s/01093/","defaultTab":"news","newsList":[{"id":"2430225330","title":"石药(01093.HK)受托人根据股份奖励计划购479万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430225330","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430225330?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:38","pubTimestamp":1714124280,"startTime":"0","endTime":"0","summary":"石药(01093.HK) 公布，受托人于4月26日(今日)根据股份奖励计划，购买479万股，平均每股价约6.554元，涉资约3,139.34万元。(ha/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-26 16:25。)AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220902171046197_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220902171046197_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1345530/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2430223901","title":"石药集团(01093)：受托人根据股份奖励计划购买合共479万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430223901","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430223901?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:36","pubTimestamp":1714124174,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团(01093)发布公告，于2024年4月26日，计划受托人根据计划之条款及条件在市场上购买合共479万股公司股份，并为获选参与者的利益以信托方式持有该等股份。平均每股代价约6.554港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111718.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430242548","title":"石药集团(01093)：高选择性MAT2A抑制剂(SYH2039)获美国临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2430242548","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430242548?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:36","pubTimestamp":1714120601,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的化药1类新药高选择性MAT2A抑制剂(该产品)已获得美国食品药品监督管理局批准，可以在美国开展临床试验。SYH2039是一种高活性甲硫氨酸腺甘转移酶2A抑制剂，可选择性杀伤MTAP缺失型肿瘤细胞，同时对正常细胞的影响较小。该产品既可单用，也可与PRMT5二代抑制剂等联用协同增效。本次获批的临床适应症为晚期恶性肿瘤。MTAP缺失肿瘤缺乏有效的靶向疗法，临床需求大，该产品极具临床开发价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111501.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430241182","title":"石药集团04月26日遭主力抛售2263万元 环比增加239.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430241182","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430241182?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:16","pubTimestamp":1714119369,"startTime":"0","endTime":"0","summary":"04月26日, 石药集团股价涨1.23%，报收6.60元，成交金额3.10亿元，换手率0.40%，振幅2.91%，量比0.97。石药集团今日主力资金净流出2263万元，上一交易日主力净流出666万元，今日环比增加239.79%。该股近5个交易日上涨14.38%，主力资金累计净流出381万元；近20日主力资金累计净流出2177万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042616164987b2a167&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042616164987b2a167&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430557295","title":"南向资金4月25日净卖出石药集团15.60万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2430557295","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430557295?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:31","pubTimestamp":1714095085,"startTime":"0","endTime":"0","summary":"4月25日，南向资金减持石药集团15.60万股连续3日减持。截止当日收盘，港股通共持有石药集团149540.38万股，占流通股12.53%。石药集团近5个交易日上涨11.26%，港股通累计增持46.46万股；近20个交易日上涨2.84%，港股通累计减持3184.12万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260941488b54f9d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260941488b54f9d2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430424230","title":"石药集团：港股医药股午后震荡走强，石药集团涨幅近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430424230","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2430424230?lang=zh_cn&edition=full","pubTime":"2024-04-25 15:11","pubTimestamp":1714029105,"startTime":"0","endTime":"0","summary":"港股医药股午后表现抢眼，石药集团股价上涨近5%港股医药板块午后强势崛起，石药集团股价猛涨近5%，远大医药紧随其后，涨幅超过4%。中国生物制药和和黄医药也表现出色，跟涨行情明显。随着全球疫情逐渐得到控制，医药行业需求有望稳步增长。值得注意的是，石药集团作为港股医药板块的领头羊，其股价的大幅上涨反映出公司业绩和市场前景的双重利好。市场分析人士指出，医药股的强势表现有望延续。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251533078b51efdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251533078b51efdd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430423980","title":"港股医药股午后震荡走强 石药集团涨近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430423980","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430423980?lang=zh_cn&edition=full","pubTime":"2024-04-25 14:29","pubTimestamp":1714026594,"startTime":"0","endTime":"0","summary":"每经AI快讯，港股医药股午后震荡走强，石药集团涨近5%，远大医药涨超4%，中国生物制药、和黄医药等跟涨。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202404253059203996.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202404253059203996.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430480224","title":"石药集团(01093)上涨5.14%，报6.54元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430480224","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430480224?lang=zh_cn&edition=full","pubTime":"2024-04-25 11:03","pubTimestamp":1714014219,"startTime":"0","endTime":"0","summary":"4月25日，石药集团(01093)盘中上涨5.14%，截至11:03，报6.54元/股，成交1.72亿元。石药集团是一家主要从事成药和原料药生产的医药公司，以创新药为核心发展战略，产品涵盖神经系统疾病、抗肿瘤、抗感染及心血管疾病等治疗领域。公司拥有全国顶尖的研发团队，研发基地分布于石家庄、上海、北京以及美国，专注于小分子靶向药物、纳米药物、单抗药物、双抗药物、抗体偶联药物以及免疫领域生物药物的发现、研究及开发。截至2023年年报，石药集团营业总收入314.5亿元、净利润58.73亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/25110340400371.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429108234","title":"石药集团(01093)出现大手买入79万股，成交价$6.18，涉资488.22万","url":"https://stock-news.laohu8.com/highlight/detail?id=2429108234","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429108234?lang=zh_cn&edition=full","pubTime":"2024-04-24 11:54","pubTimestamp":1713930840,"startTime":"0","endTime":"0","summary":"[大手成交]石药集团(01093)在上午11:54出现大手买入，成交量为79万，成交价为港币$6.18，涉资488.22万。至目前为止，股价升2.149%，今日最高价为$6.19，而最低价为$6.03，总成交量为1.77千万股，总成交金额港币$1.084亿。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2404243756/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2429219498","title":"新事 | 石药重要子公司总经理、董事同时辞任","url":"https://stock-news.laohu8.com/highlight/detail?id=2429219498","media":"健识局","top":-1,"share":"https://www.laohu8.com/m/news/2429219498?lang=zh_cn&edition=full","pubTime":"2024-04-23 20:23","pubTimestamp":1713875034,"startTime":"0","endTime":"0","summary":"4月22日，石药创新制药发布公告，总经理韩峰、董事成员王怀玉请辞。辞任后，韩峰将继续担任公司董事职务，并分管公司功能性原料相关业务；王怀玉不再担任任何职务，去向未知。石药创新制药的股票简称是“新诺威”，是石药集团旗下生产咖啡因等原料药的企业。公司对外表示，营收变动是咖啡因产品价格较去年同期下降所导致。目前，石药创新制药的总经理之位由姚兵接任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042320251687a61ee4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042320251687a61ee4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429161362","title":"石药集团(01093)：受托人根据股份奖励计划购买合共293.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429161362","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429161362?lang=zh_cn&edition=full","pubTime":"2024-04-23 17:54","pubTimestamp":1713866092,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团(01093)发布公告，于2024年4月23日，计划受托人根据计划之条款及条件在市场上购买合共293.4万股公司股份，并为获选参与者的利益以信托方式持有该等股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107625.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429332181","title":"石药集团：石药创新一季度归母净利润约7906.13万元 同比减少38.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429332181","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2429332181?lang=zh_cn&edition=full","pubTime":"2024-04-23 09:02","pubTimestamp":1713834164,"startTime":"0","endTime":"0","summary":"石药集团（01093）公布石药创新（300765.SZ）2024年第一季度业绩，营业收入约5.24亿元，同比减少27.08%；归属于上市公司股东的净利润约7906.13万元，同比减少38.86%；基本每股收益0.0676元。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-23/doc-inasuqpz0152880.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-23/doc-inasuqpz0152880.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429854201","title":"石药创新制药总经理、董事辞任","url":"https://stock-news.laohu8.com/highlight/detail?id=2429854201","media":"医药魔方","top":-1,"share":"https://www.laohu8.com/m/news/2429854201?lang=zh_cn&edition=full","pubTime":"2024-04-23 07:42","pubTimestamp":1713829325,"startTime":"0","endTime":"0","summary":"4月22日，石药创新制药即新诺威发布公告，宣布董事会收到总经理韩峰先生及董事王怀玉先生的书面辞任报告。因工作调整需要，韩峰先生申请辞任公司总经理职务，将继续担任公司董事职务，并分管公司功能性原料相关业务。韩峰先生总经理职务的原定任期届满之日为2026年4月6日。同日，新诺威发布2024Q1业绩，公司实现营业总收入5.24亿元，同比下降27.08%。此外，新诺威2024Q1归属于上市公司股东的扣除非经常性损益的净利润为7817.20万元，同比下降56.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230804368b47e01e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230804368b47e01e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429597124","title":"石药集团(01093.HK)附属石药创新首季利润7,906万人民币  倒退38.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429597124","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429597124?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:12","pubTimestamp":1713805920,"startTime":"0","endTime":"0","summary":"石药集团(01093.HK) 公布，附属石药创新(300765.SZ) 第一季度报告，实现营业收入5.24亿人民币(下同)，按年下降27.1%，主要是咖啡因产品价格下降。归属股东净利润7,906万元，倒退38.9%，每股收益6.76分。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-22 16:25。) (A股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/03/20末期业绩普通股息：港元 0.142023/11/30第三季业绩无派息2023/08/23中期业绩普通股息：港元 0.142023/05/25第一季业绩无派息 AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20230531121548386_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20230531121548386_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1344074/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2429979975","title":"新诺威：购买石药集团三家公司资产的交易正在有序进行中","url":"https://stock-news.laohu8.com/highlight/detail?id=2429979975","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2429979975?lang=zh_cn&edition=full","pubTime":"2024-04-23 00:28","pubTimestamp":1713803286,"startTime":"0","endTime":"0","summary":"此次交易构成关联交易，预计构成重大资产重组。目前，交易正在有序进行中，未发现存在可能导致公司董事会或者交易对方撤销、中止此次交易方案或对此次交易方案做出实质性变更的相关事项。自交易预案披露以来，公司及相关各方积极推进各项工作。公司将按照规定每三十日发布一次交易的进展公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230038218b46d08e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230038218b46d08e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429210559","title":"石药集团(01093)：石药创新(300765.SZ)一季度归母净利约7906.13万元 同比减少38.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429210559","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2429210559?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:35","pubTimestamp":1713792953,"startTime":"0","endTime":"0","summary":"石药集团(01093)公布石药创新(300765.SZ)2024年第一季度业绩，营...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_41.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_41.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107066.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429092370","title":"石药集团(01093.HK)4月22日回购2759.27万港元 已连续5日回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2429092370","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2429092370?lang=zh_cn&edition=full","pubTime":"2024-04-22 20:39","pubTimestamp":1713789567,"startTime":"0","endTime":"0","summary":"证券时报·数据宝统计，石药集团在港交所公告显示，4月22日以每股5.860港元至5.990港元的价格回购462.80万股，回购金额达2759.27万港元。该股当日收盘价6.000港元，上涨3.99%，全天成交额2.50亿港元。自4月16日以来公司已连续5日进行回购，合计回购2662.80万股，累计回购金额1.56亿港元。其间该股累计上涨2.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202404223054575873.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202404223054575873.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429241946","title":"富国基金俞晓斌旗下富国双债A一季报最新持仓，重仓石药集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2429241946","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429241946?lang=zh_cn&edition=full","pubTime":"2024-04-22 18:24","pubTimestamp":1713781442,"startTime":"0","endTime":"0","summary":"证券之星消息，4月22日富国基金旗下俞晓斌管理的富国双债增强债券型基金公布一季报，近1年净值增长率-3.53%。与上一季度相比，该基金前十大重仓股新增绿城中国，首旅酒店；其中石药集团持仓占比1.61%，为该基金第一大重仓股；濮阳惠成，环旭电子等退出前十大重仓股；详细数据如下：以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200022040.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429946804","title":"石药集团(01093)4月22日斥资2759.27万港元回购462.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429946804","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429946804?lang=zh_cn&edition=full","pubTime":"2024-04-22 18:20","pubTimestamp":1713781221,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团(01093)发布公告，于2024年4月22日斥资2759.27万港元回购股份462.8万股，每股回购价格为5.86-5.99港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106654.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429917200","title":"石药集团(01093.HK)授出30万份受限制股份的奖励","url":"https://stock-news.laohu8.com/highlight/detail?id=2429917200","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2429917200?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:08","pubTimestamp":1713776922,"startTime":"0","endTime":"0","summary":"格隆汇4月22日丨石药集团(01093.HK)发布公告，2024年4月22日，根据于2018年8月20日采纳的限制性股份奖励计划，向一名集团的员工(其并非公司董事、行政总裁或主要股东或彼等任何人士的联系人士)授出30万份受限制股份的奖励，惟须待承授人接纳后方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221708508b458249&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221708508b458249&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":0.13},{"period":"1month","weight":0.0399},{"period":"3month","weight":0.0885},{"period":"6month","weight":-0.021},{"period":"1year","weight":-0.1329},{"period":"ytd","weight":-0.1019}],"compareEarnings":[{"period":"1week","weight":0.088},{"period":"1month","weight":0.0768},{"period":"3month","weight":0.1065},{"period":"6month","weight":0.0145},{"period":"1year","weight":-0.1103},{"period":"ytd","weight":0.0354}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事药品生产和销售的投资控股公司。该公司以“石药”品牌销售其产品。该公司包括四个业务部门：成药部门、抗生素（中间体及原料药）部门、维生素C（原料药）部门及咖啡因及其他（原料药）部门，分别从事生产及销售相关药品业务。该公司的成药包括抗生素、心脑血管用药、糖尿病用药、精神神经用药、抗肿瘤用药及中医药产品。该公司还通过其子公司从事提供药品研发服务及污水及药物副产品处理业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.007621},{"month":2,"riseRate":0.733333,"avgChangeRate":0.097752},{"month":3,"riseRate":0.466667,"avgChangeRate":0.01981},{"month":4,"riseRate":0.6,"avgChangeRate":0.056987},{"month":5,"riseRate":0.586207,"avgChangeRate":0.038691},{"month":6,"riseRate":0.344828,"avgChangeRate":0.00713},{"month":7,"riseRate":0.366667,"avgChangeRate":0.002269},{"month":8,"riseRate":0.433333,"avgChangeRate":0.015994},{"month":9,"riseRate":0.5,"avgChangeRate":-0.005631},{"month":10,"riseRate":0.6,"avgChangeRate":0.0171},{"month":11,"riseRate":0.466667,"avgChangeRate":0.009686},{"month":12,"riseRate":0.5,"avgChangeRate":-0.014286}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}